The clinical triad of rheumatoid arthritis, leucopenia, and splenomegaly, first described by Felty in 1924,1 is now generally regarded as a unique variant of rheumatoid disease characterised by a prominence of extra-articular features as well as severe, destructive joint disease.2 A number of reviews have given a retrospective analysis of the clinical course of Felty's syndrome. 6 We report a prospective analysis of 25 patients previously described with regard to disease activity including articular changes, extra-articular features, and laboratory variables and outcome in terms of infection and death.
Material and methods
Thirty-four patients with Felty's syndrome formed an original study group evaluated at the Wellesley Hospital.2 These original patients fulfilled the following criteria for Felty's syndrome: (1) classical or definite rheumatoid arthritis (ARA criteria); (2) splenomegaly; (3) leucopenia of less than 4 x 109/l or neutropenia of less than 2 x 109/l, or thrombocytopenia of less than 100 x 109/l; (4) no other causes for cytopenia or splenomegaly.
Of the original 34 patients evaluated 16 were alive and available for recall on a prospective basis. Nine patients had died in the follow-up period, and their charts were reviewed. Five of the patients were lost to follow-up and not evaluated. Four patients were dead at the time of the first evaluation. Thus 25 patients could be evaluated according to a predesigned protocol. (Table 1 ). Of these, 11 had fewer than 5 active joints. Of the remaining 9 patients 7 continued to have essentially the same number of active joints or the same articular index, and 2 patients had more active peripheral arthritis. Comparable sets of x-rays were available in 8 patients.
There was no significant change in joint damage or radiological stage from the initial assessment.
Extra-articular manifestations of rheumatoid disease were assessed in 20 patients (Table 2) . During a mean of 5 years of follow-up there was an average 486 increase of 0 7 articular feature. It is to be noted that, in some cases, previous extra-articular features had resolved, for example, leg ulcers, lymphadenopathy, hepatomegaly, etc. Spleen size had become normal in 6 patients, and in each of these the white cell count was greater than 4 x 1 0/l. Two patients with normal white cell counts still had palpable spleens.
Sepsis. There was a history of infection in 15 of the 25 patients. These comprised bronchopulmonary infections, severe skin infections, and pyoarthrosis with Gram-positive or Gram-negative organisms. The nature of the infections and the organisms involved were similar for patients with and without splenectomies. Five of 9 deaths were related to sepsis. Seven patients had had splenectomies for infection and 5 continued to have infection despite a normal white cell count. Three of the patients who had had splenectomies for infection died of infection, one in the immediate postsplenectomy period. Six patients without splenectomy developed recurrent infection during follow-up. In 2 the white cell count was normal, and in 4 it was less than 4 (2 4-3 9) x 109/1.
Splenectomy. Eleven patients in this group underwent splenectomy (Table 3) . However, in the follow-up period since the original assessment only 2 other patients have undergone splenectomies, one for infection and one for portal hypertension. In the whole group infections remained the major indication for splenectomy, followed by severe leucopenia or persistent skin ulceration. As noted in Table 3 , infection continued to be a significant problem after splenectomy in a large number of patients. Of 10 patients who had follow-up white cell counts after splenectomy 9 had counts of greater than 5 x 1 09/l at this assessment (mean 9-2, range 4-8-16-7). Their mean granulocyte count was 4-6 (range 1-9.5) x 109/1.
Deaths. There were 9 deaths in the follow-up period. Sepsis was the primary or contributing factor in 5 group.bmj.com on June 27, 2017 -Published by http://ard.bmj.com/ Downloaded from greater than 4 x 109/l in 16 of 24 patients at the time of this assessment. This included 7 of 14 patients who had not had splenectomies and one patient who had received neither steroids nor a disease-suppressive drug. Of the remaining 6 patients in whom the white cell count had become normal 2 had taken steroids and gold, 2 had received only prednisolone, and 2 had received either chloroquine or gold. As noted previously, 9 of 10 patients who underwent splenectomy had white cell counts consistently greater than 5 x 106/1. However, at the initial assessment the mean white cell count was 4-2 x 109/l and at the present assessment the it is 4 9. The latex titre showed no significant change in the follow-up period.
Discussion
The natural history of Felty's syndrome is uncertain with respect to joint disease, extra-articular and haematological features, susceptibility to infection, and mortality. (Table 3) . Although leucopenia, skin ulcers, and portal hypertension improved after splenectomy, infections recurred in a significant number of patients whether they had been the indication for the splenectomy or not. Furthermore this sepsis was the cause of death in some these patients. Thus splenectomy was not protective for sepsis in Felty's syndrome.
The 5-year mortality was high, 9 deaths among 25 patients (36 % 5-year mortality). This compares with a 20% mortality for patients admitted to hospital with rheumatoid arthritis assessed over a 5-year period.9 There were no differences in disease duration or number of extra-articular features in the dead or the living groups of patients, though the patients who died were an average of 5 years older. Infections remained the leading cause of death in this group (5 of 9 deaths).
